Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317029,Aia19,Adjuvant induced arthritis QTL 19,2.98,,joint integrity trait (VT:0010548),left rear ankle joint diameter (CMO:0002149),10,66978955,107211142,Rat,n/a,region,qtl 1000,61325,Aia5,Adjuvant induced arthritis QTL 5,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,23444813,104060283,Rat,n/a,region,qtl 1000,2317039,Aia6,Adjuvant induced arthritis QTL 6,4.31,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),10,66978955,107211142,Rat,n/a,region,qtl 1000,12880055,Am11,Aortic mass QTL 11,,0.004,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),10,84007272,95933025,Rat,n/a,region,qtl 1000,12880396,Am13,Aortic mass QTL 13,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),10,90404397,107211142,Rat,n/a,region,qtl 1000,2306970,Anxrr22,Anxiety related response QTL 22,5.95,,fear/anxiety-related behavior trait (VT:1000241),number of periods of voluntary immobility (CMO:0001045),10,61345276,98211570,Rat,n/a,region,qtl 1000,1554317,Bmd4,Bone mineral density QTL 4,9.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),10,19816042,99406971,Rat,n/a,region,qtl 1000,2300172,Bmd57,Bone mineral density QTL 57,9.8,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),10,69738412,107211142,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,51770177,107211142,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),10,51770177,107211142,Rat,n/a,region,qtl 1000,631558,Bp137,Blood pressure QTL 137,,0.013,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,94724860,96836268,Rat,n/a,region,qtl 1000,724530,Bp149,Blood pressure QTL 149,,0.0001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,90627439,107211142,Rat,n/a,region,qtl 1000,1298069,Bp168,Blood pressure QTL 168,5.5,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),10,26521957,98003205,Rat,n/a,region,qtl 1000,1300137,Bp186,Blood pressure QTL 186,3.57,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),10,90627439,107057807,Rat,n/a,region,qtl 1000,1357344,Bp249,Blood pressure QTL 249,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,66743655,98003205,Rat,n/a,region,qtl 1000,1579915,Bp280,Blood pressure QTL 280,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,90404397,107211142,Rat,n/a,region,qtl 1000,1579919,Bp281,Blood pressure QTL 281,,0.01,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,74372084,94965338,Rat,n/a,region,qtl 1000,1642980,Bp300,Blood pressure QTL 300,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,68383129,107211142,Rat,n/a,region,qtl 1000,2292438,Bp311,Blood pressure QTL 311,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,76246085,107211142,Rat,n/a,region,qtl 1000,2313856,Bp342,Blood pressure QTL 342,4.4,0.0001,life span trait (VT:0005372),age at time of death (CMO:0001193),10,87307617,96121100,Rat,n/a,region,qtl 1000,10450495,Bp383,Blood pressure QTL 383,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,76246085,94965338,Rat,n/a,region,qtl 1000,10450498,Bp384,Blood pressure QTL 384,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,67750049,107211142,Rat,n/a,region,qtl 1000,70364,Bp72,Blood pressure QTL 72,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,51121100,96121100,Rat,n/a,region,qtl 1000,631542,Bp82,Blood pressure QTL 82,6.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,26521957,98952741,Rat,n/a,region,qtl 1000,61396,Bp9,Blood pressure QTL 9,4.8,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,68420376,107211142,Rat,n/a,region,qtl 1000,2293646,Bss25,Bone structure and strength QTL 25,10.96,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),10,69738412,107211142,Rat,n/a,region,qtl 1000,2293663,Bss33,Bone structure and strength QTL 33,9.34,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),10,69738412,107211142,Rat,n/a,region,qtl 1000,2293698,Bss43,Bone structure and strength QTL 43,5.33,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra cross-sectional area (CMO:0001689),10,59209888,104209888,Rat,n/a,region,qtl 1000,1549831,Bss6,Bone structure and strength QTL 6,4,,lumbar vertebra strength trait (VT:0010574),vertebra ultimate force (CMO:0001678),10,57576521,102576521,Rat,n/a,region,qtl 1000,2313105,Bss79,Bone structure and strength QTL 79,1.8,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),10,62057807,107057807,Rat,n/a,region,qtl 1000,2313103,Bss80,Bone structure and strength QTL 80,2,0.0001,tibia strength trait (VT:1000284),tibia midshaft endosteal cross-sectional area (CMO:0001716),10,62057807,107057807,Rat,n/a,region,qtl 1000,1354641,Bvd2,Brain ventricular dilatation QTL 2,6.36,0.001,brain ventricle morphology trait (VT:0000822),hydrocephalus severity score (CMO:0001881),10,93223816,107057807,Rat,n/a,region,qtl 1000,6893357,Bw102,Body weight QTL 102,0.5,0.36,body mass (VT:0001259),body weight (CMO:0000012),10,80515287,101325465,Rat,n/a,region,qtl 1000,6893366,Bw106,Body weight QTL 106,0.3,0.47,body mass (VT:0001259),body weight (CMO:0000012),10,70199100,107211142,Rat,n/a,region,qtl 1000,70164,Bw21,Body weight QTL 21,4.36,0.00005,body mass (VT:0001259),body weight (CMO:0000012),10,53797494,98952626,Rat,n/a,region,qtl 1000,1558652,Bw57,Body weight QTL 57,4.2,0.0008,body mass (VT:0001259),body weight (CMO:0000012),10,90910316,107211142,Rat,n/a,region,qtl 1000,2303589,Bw87,Body weight QTL 87,2,,body mass (VT:0001259),body weight (CMO:0000012),10,81285008,107211142,Rat,n/a,region,qtl 1000,70171,Cari1,Carrageenan-induced inflammation QTL 1,4.9,0.0005,hypodermis integrity trait (VT:0010550),inflammatory exudate volume (CMO:0001429),10,53797385,107211142,Rat,n/a,region,qtl 1000,61427,Cia16,Collagen induced arthritis QTL 16,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,6357896,96121100,Rat,n/a,region,qtl 1000,631267,Cia20,Collagen induced arthritis QTL 20,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,23444813,104060283,Rat,n/a,region,qtl 1000,631268,Cia21,Collagen induced arthritis QTL 21,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,14487011,104060283,Rat,n/a,region,qtl 1000,631269,Cia22,Collagen induced arthritis QTL 22,8.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,40035094,104060283,Rat,n/a,region,qtl 1000,631270,Cia23,Collagen induced arthritis QTL 23,3.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,40035094,104060283,Rat,n/a,region,qtl 1000,1302404,Cia27,Collagen induced arthritis QTL 27,2.6,0.0045,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),10,76452683,107211142,Rat,n/a,region,qtl 1000,61436,Cia5,Collagen induced arthritis QTL 5,4.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,91228102,104060283,Rat,n/a,region,qtl 1000,61449,Ciaa2,CIA Autoantibody QTL 2,7.1,,blood autoantibody amount (VT:0003725),calculated serum anti-type 2 collagen antibody titer (CMO:0001279),10,63221094,107211142,Rat,n/a,region,qtl 1000,12880384,Cm107,Cardiac mass QTL 107,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),,90404397,107211142,Rat,n/a,region,qtl 1000,12880385,Cm108,Cardiac mass QTL 108,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),,90404397,107211142,Rat,n/a,region,qtl 1000,12880395,Cm109,Cardiac mass QTL 109,,0.001,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),10,90404397,107211142,Rat,n/a,region,qtl 1000,1331791,Cm31,Cardiac mass QTL 31,3.84606,,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,29299504,107211142,Rat,n/a,region,qtl 1000,1354608,Cm33,Cardiac mass QTL 33,2.8,,heart left ventricle mass (VT:0007031),heart left ventricle wet weight (CMO:0000071),10,54809292,99809292,Rat,n/a,region,qtl 1000,1558643,Cm44,Cardiac mass QTL 44,4.8,0.0000368,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,61345276,99703528,Rat,n/a,region,qtl 1000,6893336,Cm75,Cardiac mass QTL 75,0.1,0.87,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),10,61345276,99703528,Rat,n/a,region,qtl 1000,70168,Eae12,Experimental allergic encephalomyelitis QTL 12,,0.0009,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046),10,92238497,101012337,Rat,n/a,region,qtl 1000,2292617,Ept18,Estrogen-induced pituitary tumorigenesis QTL 18,3.9,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),10,73453136,96120911,Rat,n/a,region,qtl 1000,1358188,Ept9,Estrogen-induced pituitary tumorigenesis QTL 9,3.9,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),10,73453136,96120911,Rat,n/a,region,qtl 1000,2317754,Glom25,Glomerulus QTL 25,3.5,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),10,82685200,107211142,Rat,n/a,region,qtl 1000,2316949,Gluco60,Glucose level QTL 60,3.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),10,14487011,107057807,Rat,n/a,region,qtl 1000,2300218,Hpcl2,Hepatic cholesterol level QTL 2,,,liver cholesterol amount (VT:0010498),liver cholesterol level (CMO:0001597),10,45029650,95600334,Rat,n/a,region,qtl 1000,1359017,Hrtrt21,Heart rate QTL 21,2.4,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),10,51772940,96772940,Rat,n/a,region,qtl 1000,2312672,Insul15,Insulin level QTL 15,,0.01,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),10,57134272,102134272,Rat,n/a,region,qtl 1000,2301398,Kidm38,Kidney mass QTL 38,,0.002,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),10,84007272,95933025,Rat,n/a,region,qtl 1000,12880398,Kidm67,Kidney mass QTL 67,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),10,90404397,107211142,Rat,n/a,region,qtl 1000,2303118,Mamtr7,Mammary tumor resistance QTL 7,,0.003,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,9658275,104670812,Rat,n/a,region,qtl 1000,1600367,Mcs15,Mammary carcinoma susceptibility QTL 15,4.5,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,85565469,103884409,Rat,n/a,region,qtl 1000,70193,Mcs7,Mammary carcinoma susceptibility QTL 7,2.38,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,72224939,107211142,Rat,n/a,region,qtl 1000,2298548,Neuinf7,Neuroinflammation QTL 7,3.4,,nervous system integrity trait (VT:0010566),spinal cord RT1-B protein level (CMO:0002132),10,72224939,107211142,Rat,n/a,region,qtl 1000,634320,Niddm49,Non-insulin dependent diabetes mellitus QTL 49,4.41,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),10,88539139,107211142,Rat,n/a,region,qtl 1000,61363,Oia3,Oil induced arthritis QTL 3,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,87307617,107211142,Rat,n/a,region,qtl 1000,631538,Oia5,Oil induced arthritis QTL 5,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,87055121,107211142,Rat,n/a,region,qtl 1000,4889492,Pancm2,Pancreatic morphology QTL 2,3.2,,pancreatic beta cell morphology trait (VT:0005217),ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814),10,76748906,107211142,Rat,n/a,region,qtl 1000,61354,Pia10,Pristane induced arthritis QTL 10,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,23444813,104060283,Rat,n/a,region,qtl 1000,1300107,Rf18,Renal function QTL 18,3.41,,urine output (VT:0003620),timed urine volume (CMO:0000260),10,78775516,98279596,Rat,n/a,region,qtl 1000,1576308,Schws1,Schwannoma susceptibility QTL 1,,0.0041,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),10,40035094,102359817,Rat,n/a,region,qtl 1000,1549846,Scl47,Serum cholesterol level QTL 47,3.6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),10,50574707,95574707,Rat,n/a,region,qtl 1000,2312668,Scl65,Serum cholesterol level QTL 65,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),10,57134272,102134272,Rat,n/a,region,qtl 1000,2312662,Slep8,Serum leptin concentration QTL 8,,0.05,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),10,57134272,102134272,Rat,n/a,region,qtl 1000,1298078,Stresp5,Stress response QTL 5,2.99,0.00025,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,42045676,104670812,Rat,n/a,region,qtl 1000,631530,Tls3,T-lymphoma susceptibility QTL 3,0,0.0001,thymus integrity trait (VT:0010555),percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911),10,51774612,95600334,Rat,n/a,region,qtl